Allelica's Polygenic Risk Score Achieves Recognition in 2026 ACC/AHA Guidelines Allelica announces the recognition of polygenic risk scores in the 2026 ACC/AHA Guidelines, marking a key advancement in cardiovascular risk assessment.

Allelica's Polygenic Risk Score Achieves Recognition in 2026 ACC/AHA Guidelines #United_States #San_Francisco #Allelica #Polygenic_Risk_Score #CAD_Study

Allelica Unveils AbsoluteDx: A Groundbreaking Tool for Comprehensive Genetic Risk Assessment Allelica introduces AbsoluteDx, a cutting-edge genetic test combining monogenic and polygenic assessments, aiming to redefine precision medicine.

Allelica Unveils AbsoluteDx: A Groundbreaking Tool for Comprehensive Genetic Risk Assessment #United_States #San_Francisco #Genetic_Testing #Allelica #AbsoluteDx